Pediatric Oncology | Specialty

The OncLive Pediatric Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of cancers in pediatric patients, including acute lymphoblastic leukemia, acute myeloid leukemia, brain cancers, sarcomas, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in childhood and adolescent and young adult cancers.

Blinatumomab in Acute Lymphoblastic Leukemia

January 9th 2015

Minimum Residual Disease in ALL

January 9th 2015

Asparaginase in Acute Lymphoblastic Leukemia

January 9th 2015

Chemotherapy Regimens in Patients With ALL

January 9th 2015

TKIs in Philadelphia Chromosome-Positive ALL

January 9th 2015

Vincristine in Acute Lymphoblastic Leukemia

January 9th 2015

Identifying Transplant Candidates in ALL

January 9th 2015

Induction Therapy in Adult Ph-negative ALL

January 9th 2015

Introduction: Understanding ALL and Its Prognostic Factors

January 9th 2015

Aprepitant Yields Significant Benefits for the Prevention of CINV in Children

June 28th 2014

Aprepitant is significantly more effective than a comparator placebo-added regimen in preventing CINV in children, with benefits seen across all phases of treatment.

Dr. Litzow on Transplants in Patients with ALL

March 27th 2014

Mark R. Litzow, MD, chair, ECOG-ACRIN Leukemia Committee, professor of medicine, Division of Hematology, Mayo Clinic, discusses the role of transplant in patients with acute lymphoblastic leukemia

Eribulin Shows Promise in Pediatric Sarcomas

November 21st 2013

Eribulin has demonstrated a high level of antitumor activity that was equivalent or superior to vincristine across several sarcoma xenograft models, including at low dose levels, suggesting the drug may effectively treat pediatric patients with sarcoma.

Promoting Sleep in Children With Cancer

May 30th 2013

Rebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.

Lessons on Patient Care Learned at Home

September 28th 2012

This fellow shares the insights he’s gained from his wife, a pediatric oncology nurse, and how they help in the care he provides.

Dr. Larsen Discusses Outcomes for AYA ALL Patients

June 7th 2012

Dr. Eric Larsen, from the Maine Children's Cancer Program, Discusses Outcomes for AYA Patients With Acute Lymphoblastic Leukemia

Providing Oncology Services in Impoverished Countries

April 15th 2012

Many of us training in the United States have encountered patients and their families from resource-limited regions of the world-families who have uprooted themselves for the chance to save the lives of their children diagnosed with cancer.

10 Tips for Making the Most Out of a Child's Visit With a Hospitalized Parent

March 15th 2011

Although most hospitals encourage visits from children, you should keep in mind the following tips to help ensure that those visits are happy ones for you and your kids.

Long-term effect of treatment on childhood cancer survivors

March 15th 2011

Recent reports published in the Childhood Cancer Survivor Study (CCSS) are examining the longterm or delayed health effects of cancer treatments.

Medulloblastoma Subtypes Are Different Diseases

March 11th 2011

Medulloblastoma, a malignant brain tumor that most commonly affects children, is not one disease but several, said researchers with St. Jude Children's Hospital in Memphis, Tennessee.

Modified Herpes Virus to Be Tested in Sarcoma Patients

March 9th 2011

The FDA has awarded a $600,000 grant for a phase I clinical trial of a genetically reprogrammed herpes simplex virus in young cancer patients with relapsed non-central nervous system (CNS) solid tumors such as sarcomas and neuroblastomas.